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Transforming Growth Factor- Induced Warburg-Like
Metabolic Reprogramming May Underpin the
Development of Peritoneal Endometriosis
Vicky J. Young, Jeremy K. Brown, Jacqueline Maybin, Philippa T. K. Saunders,
W. Colin Duncan, and Andrew W. Horne
Medical Research Council Centre for Reproductive Health, The University of Edinburgh, Queen’s Medical
Research Institute, Edinburgh EH16 4TJ, United Kingdom
Context: TGF- is believed to play a major role in the etiology of peritoneal endometriosis. In
tumors, TGF- induces the metabolic conversion of glucose to lactate via glycolysis, a process
referred to as the “Warburg effect.” Lactate increases cell invasion, angiogenesis, and immune
suppression, all crucial steps in the development of endometriosis.
Objective: The aim of this study was to determine whether TGF- induces a “Warburg-like” effect
in peritoneal endometriosis.
Design: The study was informed by human tissue analysis and cel culture.
Setting: The study was conducted at the university research institute.
Patients or Other Participants: We studied women undergoing surgical investigation for
endometriosis.
Interventions: Concentrations of lactate and TGF-1 in peritoneal fluid (n 16) weremeasured by
commercial assay. Expression of genes implicated in glycolysis was measured in endometrial and
peritoneal biopsies (n  31) by quantitative RT-PCR and immunohistochemistry. The effect of
TGF-1 on primary human peritoneal mesothelial cells (n  6) and immortalized mesothelial
(MeT-5A) cells (n 3) was assessed by quantitative RT-PCR, Western blot, and commercial assays.
Main Outcome Measures: Lactate, TGF-1, and markers of glycolysis were measured.
Results:Concentrationsof lactate inperitoneal fluidparalleled thoseof TGF-1, being significantly
higher inwomenwith endometriosis compared towomenwithout (P .05). Endometriosis lesions
expressed higher levels of glycolysis-associated genes HIF1A, PDK1, and LDHA than eutopic en-
dometrium, and adjacent peritoneum had higher levels of HIF1A and SLC2A1 than peritoneum
fromwomenwithoutdisease (P .05 toP .001). Exposureofmesothelial cells toTGF-1 increased
production of lactate (P  .05), increased HIF1A mRNA (P  .05), and protein, and increased
concentrations of mRNAs encoded by glycolysis-associated genes (LDHA, PDK1, SLC2A1; P  .05).
Conclusions: A change in the metabolic phenotype of endometriosis lesions and peritoneal
mesothelium in women with endometriosis may favor development of endometriosis. (J Clin
Endocrinol Metab 99: 3450–3459, 2014)
Endometriosis is a nonmalignant disorder defined as thepresence of endometrial tissue outside the uterus,
most commonly on the pelvic peritoneum, in close asso-
ciationwith the peritoneal mesothelial cells (PMCs) (1). It
is thought to affect 6–10% of women of reproductive age
and is associated with chronic pelvic pain, dysmenorrhea,
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and infertility (2). Endometriosis is currently managed
surgically or medically, but symptoms can recur in up to
75% of surgical cases, and available medical treatments
have undesirable side effects (3).
The major obstacle in the development of new agents
for the treatment of endometriosis is our limited under-
standing of its etiology. A widely accepted hypothesis is
that retrogrademenstruation through the fallopian tube is
a means for the transfer of endometrial tissue into the
peritoneal cavity, where it implants on themesotheliumof
the peritoneum (4). However, the reason this occurs in
somewomenandnot inothers is notknown.Todate,most
research into the etiology of endometriosis has focused on
changes within eutopic and ectopic endometrium, but
there are limited data on the role of the peritoneum (5).
The TGF- superfamily is thought to play a major role
in the development of endometriosis (6). In studies using
a mouse model of endometriosis, TGF--null females de-
velop fewer and smaller peritoneal endometriosis lesions
than their wild-type counterparts (7). In women, expression
of TGF- superfamily members and their signaling compo-
nents appear to be dysregulated in the eutopic endometrium
in women with endometriosis (8), and concentrations of
TGF- in peritoneal fluid are increased in women with en-
dometriosis compared to women without disease (9–11).
However, theunderlyingmechanism(s) influencedby theac-
tions of TGF- remains poorly understood.
It is recognized that endometriosis and tumorigenesis
share clear parallels (12–14). During tumorigenesis, TGF-
can induce a shift in cell metabolism from mitochondrial
oxidative phosphorylation to aerobic glycolysis, known as
the “Warburg effect” (15–17). Neighboring cells of tumors
are also programmed to use aerobic glycolysis by TGF-1,
and this process generates lactate, which feeds adjacent tu-
mor cells, establishing an integrated metabolic tumor mi-
croenvironment (16, 18). Overproduction of lactate in-
creases cell invasion,angiogenesis, and immunesuppression,
all crucial steps in the development of tumors and known
regulators of endometriosis (19).
One key factor in this pathway is hypoxia inducible
factor-1 (HIF-1), a heterodimer composed of HIF-1
(HIF1A) and HIF-1 subunits (20). HIF-1 is constitu-
tively expressed in cells, whereas HIF-1 is hydroxylated
at two proline residues before binding the von Hippel-
Lindau protein for ubiquitination and proteasomal deg-
radation in the presence of oxygen. Because oxygen is
needed for the hydroxylation, hypoxic conditions lead to
HIF-1 stabilization, and thus activity (20). HIF-1 pro-
tein has previously been detected in normoxic conditions.
The mechanism for this normoxic stabilization remains
unclear but may occur through various signaling path-
ways that block HIF-1 ubiquitination (21) or by in-
creased HIF1A gene expression or translation enabling
protein production at a greater rate than proteasomal deg-
radation (22–25). HIF-1 is a key mediator of glycolysis
and induces the expression of several key genes in the
glycolysis pathway. These include lactate dehydrogenase
A (LDHA), which converts pyruvate to lactate, and py-
ruvate dehydrogenase kinase 1 (PDK1), which suppresses
mitochondrial oxidative metabolism by inhibiting pyru-
vate dehydrogenase and the conversion of pyruvate to
acetyl coenzyme A needed for the tricarboxylic acid cycle
as well as glucose transporter 1 (SLC2A1), which is re-
sponsible for increased glucose uptake by the cell (26, 27).
Studies have shown HIF-1 to be expressed in endo-
metriosis lesions, and this expression is significantly in-
creased compared to matched eutopic endometrium and
healthy control endometrium (28, 29). Although these
studies refer to the transient hypoxia experienced by shed
ectopic endometrial cells during lesion development (28,
30, 31), to date no link has been reported between in-
creased concentrations of TGF- in the peritoneal fluid
and HIF1A expression.
The aim of our study was to determine whether there
are changes in themetabolic phenotype and production of
lactate in the peritoneum of women with endometriosis,
similar to the Warburg effect reported in cancers, which
would provide an environment favorable for the mainte-
nance and growth of lesions. First, we correlated levels of
TGF- and lactate in the peritoneal fluid of women with
andwithout endometriosis.We then examined expression
of glycolysis genes (includingHIF1A,LDHA, PDK1, and
SLC2A1) in endometrial, peritoneal, and endometriosis
lesion biopsies from women with and without endome-
triosis. Finally, we examined the effect of TGF-1 on lac-
tate production and expression of glycolysis markers in
primary human peritoneal and immortalized mesothelial
(MeT-5A) cells.
Subjects and Methods
Subjects
Ethical approval for this studywasobtained from theLothian
Research Ethics Committee (LREC11/AL/0376),with informed
written consent obtained from all patients. All of the women
included in this study underwent surgery for investigation of
chronic pelvic pain to identify underlying endometriosis. The
“control” group of women had no evidence of endometriosis at
laparoscopy, nor was there evidence of any other underlying
pelvic pathology to explain their painful symptoms (eg, adhe-
sions). None of the women were taking hormonal contracep-
tives, and they all had regular 21- to 35-day menstrual cycles.
Women were operated on once during this study. Peritoneal
fluid, primary PMCs, peritoneal biopsies, endometrial biopsies,
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and endometriosis lesionbiopsieswere obtained at the beginning
of surgery.
In women with endometriosis (n  15), we recovered endo-
metriotic lesions (for study and histological confirmation of dis-
ease) andperitoneumadjacent anddistal to lesions (for studyand
histological conformation of the absence of disease) and endo-
metrial biopsies. In women without endometriosis (n 16), we
biopsied the peritoneum at locations within the abdomen at
similar locations to those obtained from patients (for study
and histological confirmation of the absence of disease). The
tissues were collected according to the Endometriosis Phenome
and Biobanking Harmonisation Project (EPHect) guidelines
(http://endometriosisfoundation.org/ephect/).
Peritoneal biopsies and endometriosis lesion biopsies were
divided into twoportions; onewas immersed inRNAlater at 4°C
for 24 hours and frozen at 80°C for RNA extraction, and the
other portion was fixed in 4% neutral-buffered formalin for 24
hours at 4°C, followed by storage in 70% ethanol, and subse-
quent embedding in paraffin wax for later immunohistochem-
istry. Peritoneal fluid was collected from women with endome-
triosis (n 8) and women without endometriosis (n 8) at the
beginningof surgery. PrimaryPMCswere collected fromwomen
with and without endometriosis (n 6) as previously described
by gentle scraping of the pelvic mesothelium with a Tao brush,
followed by vigorously agitating in 15 mL of serum-containing
culture media to dislodge cells (QC Sciences) (32). We found no
difference in responseofprimary cells toTGF-whencomparing
the 2 groups.
Cycle staging
Cycle phase was determined by examination of endometrial
biopsies (stained with hematoxylin and eosin) collected at the
same time as the peritoneal fluid samples. An expert histopathol-
ogist who used Noyes’ criteria to determine cycle phase exam-
ined the samples. Cycle phase was also confirmed by the mea-
surement of serum estradiol and progesterone levels together
with day of the cycle.
Establishment of cell culture
Cells were cultured as previously described (33) in HOSE I me-
dia, 40% Media 199, 40% MCDB 105, and supplemented with
15% fetal bovine serum, 0.5% penicillin/streptomycin, and 1%
L-glutamine (Life Technologies Inc and Sigma Chemical Co).
The MeT-5A cell line (CRL-9444; ATCC) was originally es-
tablished by transfecting normal human mesothelial cells from
the plural cavity with a plasmid containing Simian virus (SV40)
early region DNA, and it expresses SV40 large T antigen
(ECACC) (10, 11). MeT-5A cells were grown in Iscove’s Mod-
ified Dulbecco’s Media supplemented with 10% fetal bovine
serum and 1% L-glutamine (Life Technologies Inc).
Experimental treatments of primary PMCs and
MeT-5A cells
Cells were plated at either 1.5  105 in a 12-well plate for
primaryPMCsor2105 in a12-well plate forMeT-5Acells and
left to seed for 12 hours before serum starving for 24 hours.
Cells were exposed to physiological levels (34) of recombi-
nant human TGF-1 (2 ng/mL) as previously described (10, 11)
for between 3 and 48 hours (PeproTech EC Ltd and R&D Sys-
tems). Cells were harvested in RLT buffer containing 0.01%
-mercaptoethanol and stored at 80°C until RNA extraction
(QIAGEN). For protein analysis, cells were harvested inNuPage
LDSsamplebufferdiluted1:4withaddeddithiothreitol andHalt
protease-phosphatase inhibitor cocktail (Life Technologies Inc
and Thermo Fisher Scientific). Lysates were prepared by removal
of DNA contamination in a QIAshredder spin column (QIAGEN).
Media was removed and stored at 80°C for analysis.
Lactate assay
Lactate concentrationwas determinedusing a commercial kit
(Randox Laboratories Ltd) adapted for use on a Cobas Fara
centrifugal analyzer (Roche Diagnostics Ltd). The minimal de-
tectable concentration with an acceptable level of precision was
determined as 0.15 mmol/L, and the test was linear up to an
L-lactate concentration of 19 mmol/L. The within-batch coeffi-
cientof variation (CV)was0.9%,and thebetween-batchCVwas
2.7% at a value of 1.26 mmol/L.
TGF-1 immunoassay
A TGF-1 ELISA was performed using a Human TGF-1
Quantikine Kit (DB100B; R&D Systems) according to the man-
ufacturer’s instructions. Samples were diluted 1:2, and latent
TGF-1 was activated to the immunoreactive form using 1 M
HCl and neutralized with 1.2 M NaOH/0.5 M HEPES buffer
before assaying. Samples were assayed in duplicate, and after
development assays were measured on a Lab SystemsMultiscan
EXMicroplate reader at 450 nm with wavelength correction at
540nm.Valueswere determinedby standard curve analysiswith
a detection limit of 16 pg/mL and linear range from 16 to 1000
pg/mL. Intra-assay CV is 2.5%, and the between-batch CV is
8.3% for cell culture supernatants.
Cell proliferation assay
Cell proliferation was measured using CyQuant cell prolif-
eration assay kit (Invitrogen) according to the manufacturer’s
instructions. Cells were pretreated with Ribonuclease A (Sigma
Chemical Co) to remove any contaminating RNA before assay.
Platesweremeasured on FluroStarOptima at 480 nm.Cell num-
ber was calculated by a standard curve with an assay linear de-
tection range of between 50 and 50 000 cells.
Immunostaining
Paraffin-embedded peritoneal biopsies and endometriosis
lesion biopsies were cut into 5-m sections, mounted onto elec-
trostatically charged microscope slides, dewaxed, and rehy-
drated (VWR International Ltd). Antigen retrieval was pre-
formed by pressure cooking slides for 5 minutes in 10 mM Tris 1
mM EDTA (pH 9). Slides were blocked for 30minutes in normal
horse serum diluted 1:6 in Tris-buffered saline with 0.05%
Tween 20 before incubation with primary antibody (Biosera).
Primary antibodies included:HIF-1, 1:100 (10790; Santa Cruz
Biotechnology); glucose transporter-1 (GLUT-1), 1:1000
(ab652; Abcam Inc); PDK-1, 1:2000 (NBP1-96065; Novus Bi-
ologicals); LDHA, 1:1000 (ab52488; Abcam Inc); or rabbit IgG
(X0903; Dako). Sections were washed in TBS-T20 and incu-
bated for 30 minutes with species-specific impress kit (Vector
Laboratories). Sections were then washed, incubated for 5 min-
utes with 3,3-diaminobenzidine (Vector Laboratories), coun-
terstained with hematoxylin, dehydrated, mounted, and visual-
ized by light microscopy. Images were captured using an
Olympus Provis microscope equipped with a Kodak DCS330
camera (Olympus Optical Co and Kodak Ltd). A total of 12
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peritoneal biopsies, four endometriosis lesions, and four endo-
metrial biopsies were examined using immunohistochemistry.
For cell culture immunofluorescence, cells were fixed in ice-
cold methanol for 15 minutes before being washed in TBS-T20,
then blocked in normal horse serum as above. Cells were incu-
bated with mouse anti-HIF-1 (2.5 g/mL, 610958; BD Biosci-
ences) or equimolar concentrations of mouse IgG (2.5 g/mL,
M7894; Sigma Chemical Co) at 4°C overnight. Cells were
washed in TBS-T20 and incubated for 30 minutes with species-
specific impress kit (Vector Laboratories). After washes in TBS,
sections were incubated with Tyramide and counterstainedwith
DAPI, before visualizing with wide field microscopy (PerkinEl-
mer). Images were captured using an Axiovert 200M equipped
with an Axiocam HRc camera (Carl Zeiss). A total of three
MeT-5A cultures were examined using immunofluorescence.
RNA preparation and cDNA synthesis
RNA was extracted using the RNeasy Mini kit with on-col-
umnDNaseI digestion (QIAGEN) according to themanufactur-
er’s instructions. First-strand cDNA synthesis was performed
using Superscript VILOMaster Mix (Life Technologies Inc) ac-
cording to the manufacturer’s instructions.
Quantitative RT-PCR analysis
mRNAtranscriptswere quantified relative to the appropriate
housekeeping gene, GAPDH, as determined by geNorm assay
(Primerdesign Ltd). Reactions were performed using an ABI
Prism 7900 Fast system under standard running conditions with
brilliant III ultrafast SYBR green QPCR master mix (Applied
Biosystems and Agilent). Melt curves were analyzed to confirm
specific products with prevalidated primers and quantification
using the 2Ct or the 2Ct method after normalization
against controls (Primerdesign Ltd).
Immunoblotting
Cell lysates (at a concentration of 200000 cells/200 L, with
10 L loaded onto each lane) were resolved on NuPage Novex
4–12%Bis-Tris polyacrylamide gels (Life Technologies Inc) un-
der reducingconditionswithNuPageMOPSSDSrunningbuffer,
according to the manufacturer’s instructions. Proteins were
transferred to a polyvinylidene difluoride membrane using a
semidry blotter and blocked with 5%milk powder in Tris-buff-
ered saline with 0.1%Tween 20 (TBS-T20). Themembranewas
incubated with mouse anti-GAPDH (0.5 g/mL, G9545; Sigma
Chemical Co) in TBS-T20 and 5% milk for 2 hours at room
temperature, before incubating with anti-HIF-1 (1 g/mL,
610958; BD Biosciences) at 4°C overnight in TBS-T20 and 5%
milk overnight at 4°C. After this, membranes were washed and
incubated with species-specific impress kit 1:10 000 (Vector
Laboratories Ltd) in TBS-T20 and 5% milk for 1 hour at room
temperature. The membrane was washed and incubated with
Tyramide for 30 minutes and imaged with Fujifilm FLA-5100
Fluorescent Image Analyzer (PerkinElmer and Fugifilm Ltd).
Statistical analysis
All results are expressed as mean  SEM of a minimum of
three independent experiments. ELISA and lactate assay data
were analyzed using unpaired Student’s t test andwere log-trans-
formed before Pearson correlation testing. Quantitative RT-
PCR, cell proliferation, and cell cytotoxicitywere analyzed using
paired and unpaired Student’s t tests, as appropriate. All statis-
tical results were generated using GraphPad PRISM version 5
statistical software (GraphPad Software, Inc), and P  .05 was
considered significant.
Results
Lactate concentrations are increased in the
peritoneal fluid of women with endometriosis,
and these correlate positively with peritoneal fluid
TGF-1 levels
Because TGF- is known to be increased in the perito-
neal fluid of women with endometriosis (16) and TGF-1
Figure 1. A and B, TGF-1 (A) and lactate (B) levels were increased in
peritoneal fluid from women with endometriosis compared to women
without endometriosis during the secretory phase of the menstrual
cycle. C, There was a significant positive correlation across the
menstrual cycle between levels of TGF-1 and lactate in women with
and without endometriosis. *, P  .05; R2  0.3589 (n  2 each
proliferative group, n  6 each secretory group).
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is known to increase lactate levels (16), we investigated
whether TGF-1 concentrations correlated with those of
lactate in the peritoneal fluid of women with and without
endometriosis. TGF-1 concentrations (Figure 1A) and
lactate levels (Figure 1B) were significantly increased in the
peritoneal fluid of women with endometriosis compared to
women without endometriosis in the secretory phase of the
cycle. The same sample set was used for both assays, andwe
found a significant positive correlation between concentra-
tions ofTGF-1and lactate in the peritoneal fluid ofwomen
with and without endometriosis (Figure 1C).
Aerobic glycolysis marker expression is increased
in endometriosis lesions compared to eutopic
endometrium
To investigate whether endometriosis lesions use aer-
obic glycolysis as a means of metabolism, we measured
expression of glycolysis markers in endometriosis lesions
compared to eutopic endometrium from women with en-
dometriosis. Concentrations of mRNAs encoded by
HIF1A,PDK1, andLDHAwere significantly increased in
endometriosis lesions when compared to eutopic endo-
metrium fromwomenwith endometriosis (Figure 2, A, C,
and D). However, no change was found in the expression
of SLC2A1 (Figure 2B). Endometriosis lesions stained
positive for HIF1A, PDK-1, LDHA, and GLUT-1 in the
glandular epithelium and surrounding stromal cells (Fig-
ure 2E). No staining was observed in the negative control
sections (Figure 2E).
Aerobic glycolysis marker expression is increased
in the peritoneum of women with endometriosis
compared to women without endometriosis
To investigate whether the peritoneum is a source of
lactate, expression of genes associated with the regulation
of aerobic glycolysis was quantified in peritoneal biopsies
from women with and without endometriosis. Concen-
trations of mRNAs encoded byHIF1A and SLC2A1were
significantly increased in peritoneal biopsies adjacent to
endometriosis lesionswhencompared toperitoneumfrom
women without endometriosis (Figure 3, A and B). There
was no difference in either HIF1A or SLC2A1 mRNA
concentrations between peritoneal biopsies distal to en-
dometriosis lesions and peritoneum fromwomenwithout
Figure 2. HIF1A (A), PDK1 (C), and LDHA (D) mRNA concentrations were significantly increased in endometriosis lesions when compared to
endometrium from women with endometriosis. B, There was no significant change in SLC2A1 mRNA expression between endometriosis lesions
and endometrium from women with disease. E, HIF-1, GLUT-1, PDK-1, and LDHA were expressed in glandular epithelial cells and surrounding
stromal cells of endometriosis lesions and endometrium. There was no staining in sections probed with control antibodies. **, P  .01; ***, P 
.001; ****, P  .0001 (n  7 each group mRNA analysis, n  2 each group immunohistochemical analysis). Original magnification, 400.
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endometriosis. mRNAs encoded by LDHA and PDK1
weredetected inall samples, but expressiondidnot change
between women with and without endometriosis, nor did
it change between sites (Figure 3, C and D). HIF1A,
PDK-1, LDHA, andGLUT-1 protein could be localized to
mesothelial cells and some stromal cells in peritoneal bi-
opsies in the presence or absence of endometriosis (Figure
3E). No staining was observed in the negative control sec-
tions, and no endometriosis was detected in peritoneum
adjacent to lesions (Figure 3E).
TGF-1 increases lactate production in primary
human PMCs and immortalized mesothelial cells
(MeT-5A)
To determine whether TGF-1 increases the produc-
tion of lactate in mesothelial cells, primary human PMCs
and an immortalized mesothelial cell line (MeT-5a) were
treatedwith a physiological concentration ofTGF-1 (10,
11). Cell culture supernatants from PMCs treated with 2
ng/mLTGF-1 for 12 hours produced significantly higher
levels of lactate than control untreated PMCs (Figure 4A).
MeT-5A mesothelial cells also showed significantly in-
creased expression of lactate when treated with 2 ng/mL
TGF-1 at 24 hours (Figure 4B). Because increasing
amounts of lactate can be associated with increasing cell
turnover, we tested the cell proliferation of MeT-5A cells
in culturewhen treatedwithandwithoutTGF-1.Wesaw
no changes in cell number between TGF-1-treated cells
and control cells at 12 and 24 hours (Figure 4C).
TGF-1 increases HIF-1 mRNA concentration and
increases HIF-1 protein levels in PMCs
To address the question of how TGF-1 increases lac-
tate levels in the peritoneal fluid of women with endome-
triosis, we assessed the effects of TGF-1 on HIF1A ex-
pression and HIF1A stabilization in vitro. TGF-1
significantly increased HIF1A mRNA concentrations in
primary PMCs (Figure 5A) and in MeT-5A cells after 12
hours of treatment (Figure 5B). Immunofluorescent stain-
ingofMeT-5Acells showedHIF1Aprotein tobe increased
Figure 3. A and B, HIF1A (A) and SLC2A1 (B) mRNA concentrations were significantly increased in peritoneum adjacent to endometriosis lesions
when compared to peritoneum of women without disease. There was no significant change in HIF1A and SLC2A1 expression from sites of
peritoneum distal to endometriosis lesions and peritoneum from women without endometriosis. C and D, PDK1 (C) and LDHA (D) were expressed
at all sites of peritoneum biopsied; however, there was no change in expression between women with and without endometriosis. E, HIF-1,
GLUT-1, PDK-1, and LDHA were expressed in PMCs of peritoneum from women with and without endometriosis. There was no staining in
sections probed with control antibodies. *, P  .05 (n  13 peritoneal control, n  11 peritoneum distal, and n  4 peritoneal adjacent, for
mRNA analysis; n  2 in each group for immunohistochemical analysis). Original magnification, 400.
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on treatment with TGF-1 after 24 hours with HIF1A
localized to the nucleus in these cells (Figure 5C).MeT-5A
cells treated with TGF-1 for 24 hours showed increased
concentrations on Western blots, consistent with protein
stabilization (Figure 5D). Taken together, these data sug-
gest thatTGF-1up-regulates transcriptionofHIF1Aand
increases HIF-1 protein in PMCs.
TGF-1 increases concentrations of mRNAs
encoded by HIF-1 target genes involved in
glycolysis in primary human PMCs and MeT-5A
cells
To investigate the role of HIF-1 in PMCmetabolism,
we analyzed expression of several HIF-1 target genes
involved in glycolysis: LDHA, PDK-1, and SLC2A1. As
shown in Figure 6, A–C, concentrations of mRNAs en-
coded by LDHA and SLC2A1 but not PDK1 are signifi-
cantly increased in primary human PMCs by TGF-1 at
12 hours. As shown in Figure 6, D and E, expression of
LDHA, PDK1, and SLC2A1 was increased in MeT-5A
cells by TGF-1.
Discussion
We present novel data demonstrating that there are met-
abolic changes in endometriosis lesions and the surround-
ing peritoneum, consistent with the induction of a War-
burg-like effect reminiscent of the one that occurs during
tumorigenesis. We have shown that lactate, a by-product
of glycolysis, is increased in the peritoneal fluid of women
with endometriosis and that lactate concentrations posi-
tively correlate with increasing TGF-1 levels in the peri-
toneal fluid. In addition, we have shown that metabolic
drivers HIF1A, PDK1, and LDHA are increased in endo-
metriosis lesions, andHIF1A and SLC2A1 are increased in
peritoneum adjacent to endometriosis lesions, suggesting a
metabolic change similar to that of the Warburg effect. We
have also shown that TGF-1 increases expression of key
enzymes in the glycolysis pathway and lactate production in
PMCs that may provide a high-energy metabolite to feed-
forward to the endometriotic cells in a paracrine fashion to
promote endometriosis lesion development.
TGF-1 levels were significantly increased within the
peritoneal fluid of women with endometriosis when com-
pared towomenwithoutduring the secretoryphase.These
results correspond to several studies within the literature
demonstrating TGF- and TGF-1 levels to be increased
in women with endometriosis and that TGF- levels are
cyclically regulatedwithin the peritoneal fluid (9–11).We
have shown that lactate concentrations positively corre-
lated with those of TGF- within the peritoneal fluid
across themenstrual cycle. Lactate is ametabolic by-prod-
uct of glycolysis, and increasing lactate concentrations can
increase cell migration and invasion, angiogenesis, and
immune escape during tumorigenesis, all ofwhich are also
implicated in the development of endometriosis (19). In-
creased lactate may therefore help facilitate ectopic endo-
metrial cell survival and lesion establishment in a similar
fashion to that of cancer cell metastasis. Furthermore, in-
creasing lactate concentrations can lower pH and can ac-
tivate latent TGF-1, and this may initiate a positive feed-
back loop for the increasing TGF-1 and lactate levels.
Acid activation of the TGF- ligand by increasing
amounts of lactate has been shown to induce myofibro-
blast differentiation, which may lead to epithelial to mes-
enchymal transition within the adjacent peritoneum or
Figure 4. PMCs and MeT-5A cells were exposed to 2 ng/mL TGF-1
for 12 hours or for 12 and 24 hours, respectively. A and B, TGF-1
treatment resulted in a significant increase in lactate expression at 12
hours in PMCs (A) and 24 hours in MeT-5A cells (B). Lactate levels
significantly increased over time in both the TGF-1 treatment and the
control group. C, Exposure of MeT-5A cells to TGF-1 (2 ng/mL)
showed no change in cell number compared with control. *, P  .05
(n  5 PMCs, n  3 MeT-5a).
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lesions, again facilitating ectopic endometrial cell invasion
(36, 37). Importantly, because levels of lactate have been
shown to be positively correlated with the incidence of
metastases (19), in vivo assessment of lactate may have
utility as a biomarker for endometri-
osis and its response to treatment.
Endometriosis lesions expressed
significantly higher levels of HIF1,
PDK1, and LDHA mRNA when
compared to eutopic endometrium
from women with endometriosis.
This observation suggests that endo-
metriosis lesionsundergoa change in
metabolism,which is consistentwith
aerobic glycolysis and the Warburg
effect seen in tumorigenesis, despite
being established lesions with their
own vascular and presumed nor-
moxia (38).Wehave also shown that
the peritoneumadjacent, but not dis-
tal, to endometriosis lesions had sig-
nificantly increased expression of
HIF1A and SLC2A1 compared to
peritoneum from women without
endometriosis; however, we saw no
significant changes in gene expres-
sion of PDK1 orLDHA between the
groups. This lack of difference is
likely due to the fact that the perito-
neal biopsies and endometriosis lesions contain additional
cell types other than mesothelial cells (eg, endometrial ep-
ithelium and stroma, adipocytes) that likely express these
Figure 5. A and B, TGF-1 treatment (2 ng/mL) significantly up-regulated HIF-1 gene
expression in PMCs (A) and MeT-5A cells (B) after 12 hours. C, MeT-5A cells treated with TGF-1
for 24 hours showed increased HIF-1 levels and localization within the nucleus by green
immunofluorescence staining. D, MeT-5A cells treated with TGF-1 in normoxic conditions for
24 and 48 hours showed stable expression of HIF-1a protein compared to controls. *, P  .05
(n  6 PMCs, n  3 MeT-5A).
Figure 6. TGF-1 treatment (2 ng/mL) up-regulated LDHA and SLC2A1 mRNA expression at 12 hours in PMCs (A and C) and at 24 hours in MeT-
5A cells (D and F). PDK-1 was up-regulated by TGF-1 in PMCs at 12 hours (B), but this was not significant; however, PDK-1 was significantly up-
regulated by TGF-1 in MeT-5A cells at 24 hours (E). *, P  .05; **, P  .001 (n  6 PMCs, n  3 MeT-5A cells).
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genes in different amounts. Further analysis of peritoneal
biopsies demonstrated HIF-1, GLUT-1, PDK-1, and
LDHA to be localized to the peritoneal mesothelium, and
in vitro analysis of primary PMCs displayed significant
increased expression of all markers. We propose that the
peritoneum adjacent to lesions may have been repro-
grammed touseglycolysis as ameansof energyproduction
and that lactate produced by peritoneal cells could be
taken up by adjacent endometriotic cells in a feed-forward
mechanism to facilitate the establishment of an integrated
microenvironment at sites of peritoneal endometriosis
that promotes its establishment and progression. In sup-
port of this, electron microscopy studies have also de-
scribed unusually small mitochondria within lesions, con-
sistentwith glycolysis (39). Similarly, increasedglycolysis is
a common feature of all cancers, even in normoxia, and this
is thought to be an important early event during tumorigen-
esis (40). Recent studies have described cells adjacent to tu-
mors toproduce increasing lactate concentrations,whichare
thought to drive tumor development, known as “the reverse
Warburg effect” (18).Given the parallels already knownbe-
tween tumorigenesis and endometriosis (12–14), these ob-
servations provide additional data to support the hypothesis
that these pathologies share similar underlyingmechanisms.
In addition, we have shown that TGF-1 is able to
increaseHIF1AmRNA expression andHIF-1 protein in
both primary human PMCs andMeT-5A cells. TGF-1 is
known to induce stable HIF-1 expression in normoxic
conditions by overcoming the degradation pathway (35);
however, there are reports of increased rates of transcrip-
tion or translation overcoming the protein degradation in
normoxic conditions (22–25). We have not investigated
the mechanism of HIF-1 protein presence because this is
outside the scope of the paper. The increase we see may be
due to increased transcription, translation, or stabilization.
HIF-1 is a transcription factor that has already been
shown to directly regulate key genes involved in the gly-
colysis pathway (19). These genes include glucose trans-
porters such as SLC2A1, and enzymes involved conver-
sion of pyruvate to lactate (LDHA) and inhibition of
mitochondrial oxidative metabolism through inhibition
of pyruvate dehydrogenasebyPDK1 (36).Our cell culture
analysis showed increased concentrations of mRNAs en-
coded by LDHA, PDK1, and SLC2A1 in primary human
PMCs and in MeT-5A cells after 24 hours of TGF-1
treatment, suggesting that altered expression of these
genes may follow HIF-1 stabilization. This suggestion is
also supported by the observation that there was no de-
tectable HIF-1 protein in MeT-5A cells at 12 hours by
Western blot (data not shown). These results demonstrate
that TGF-1 is regulating genes that are involved in the
glycolysis pathwayandareHIF-1 regulated in thePMCs.
Our data show for the first time that lactate is signifi-
cantly increased in the peritoneal fluid of women with
endometriosis and that this correlates to increasing levels
ofTGF-1.Taken togetherwithourobservation thatboth
the endometriosis lesions and peritoneum adjacent to en-
dometriosis lesions express significantly higher levels of
glycolysis markers, these results suggest a possible change
in themetabolic phenotype, similar to that of theWarburg
effect seen in tumorigenesis. Increasing lactate production
by peritoneal tissue and within the peritoneal fluid may
“feed”ectopic endometrial cells, allowing themto survive,
implant, and invade into the peritoneum, resulting in en-
dometriosis lesions. These results may inform new bio-
marker strategies, such as in vivo lactate assessment (18),
and treatment targets for endometriosis, such as HIF-1
inhibitors (20).
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